ELAB - Total Utang marang Modal Elevai Corp

Logo perusahaan publik Elevai Labs Inc. (ELAB)

Elevai Labs Inc. (ELAB) maintains a stable liquidity level, with revenue from premium cosmetics fully offsetting current expenses. This daily price chart for the total debt-to-equity metric stands at 0.83, complementing management's strategy to implement regenerative technologies into aesthetic medicine. The production of innovative products is based in a California complex, where international quality standards are strictly observed.

ELAB: Total Utang marang Modal Elevai Labs 21.02.2024 - 30.10.2026

Rincian analitis perusahaan Elevai Labs Inc.

- rega lan prakiraan konsensus rega:
Bagan rega Elevai Labs|ELAB - Bagan tingkat prakiraan
- statistik kapitalisasi pasar:
Kapitalisasi pasar Elevai Labs|ELAB - Nilai Dipunlarasaken Utang lan Kas
- indikator kapitalisasi buku:
Nilai Buku saben Saham Elevai Labs|ELAB - Kapitalisasi Buku|Rasio Nilai Pasar marang Nilai Buku elevaiskincare.com|ELAB - Nilai Agregat Aset
- indikator total utang lan likuiditas perusahaan:
Utang marang Ekuitas Elevai Labs Inc.|ELAB - Rasio utang jangka dawa marang ekuitas|Utang jangka cendhak marang modal Elevai Labs Inc.|ELAB - Gunggung utang perusahaan|Utang marang nilai buku Elevai Labs|ELAB - Silihan lan utang jangka dawa perusahaan|Utang jangka cendhak perusahaan Elevai Labs|Likuiditas cepet elevaiskincare.com
- informasi bathi lan kelipatan valuasi:
ELAB - Bathi resik
Analisis dhasar perusahaan:Elevai Labs
Barang utama Elevai Corp

The total debt-to-equity ratio measures the proportion of borrowed funds relative to equity, determining the extent to which the financing structure depends on creditors. By analyzing the company's financial leverage dynamics, an investor assesses the default resilience of Elevai Labs Inc. (ELAB), taking into account the high capital expenditures required to maintain a specialized cold chain for the delivery of exosome serums.

Analisis pesaing Elevai Labs Inc.

Utang marang Ekuitas Krystal Biotech|Apogee Therapeutics Inc - Utang Agregat marang Ekuitas|Total Utang marang Modal ARQT|VCEL (Vericel Inc.) - Rasio Kabeh Utang marang Dana Pribadi|Total Utang marang Modal ORKA (Oruka Therapeutics Inc)|Total Utang marang Modal Sanara MedTech, Inc. SMTI|DBVT - Utang marang Ekuitas|Rasio Kabeh Utang marang Dana Pribadi SLSN (Solesence Inc)|journeymedicalcorp.com (DERM) - Utang marang Ekuitas|Rasio Total Utang marang Ekuitas Forte Biosciences Inc|EMPG (Empro Group Inc) - Total Utang marang Modal|Total Utang marang Modal sol-gel.com|Rasio Total Utang marang Ekuitas AXIL (AXIL Brands, Inc.)|MDCX (Medicus Pharma Ltd) - Rasio Kabeh Utang marang Dana Pribadi|Utang marang Ekuitas Verrica Pharmaceuticals Inc. VRCA|Koefisien Total Utang marang Modal Hoth Therapeutics Inc. (HOTH)|BFRI - Utang marang Ekuitas|VYNE - Total Utang marang Modal|SNOA: Total Utang marang Modal|QNRX - Koefisien Total Utang marang Modal|Utang marang Ekuitas Azitra Corp|Rasio Utang marang Ekuitas DRMA (Dermata Corp)|Total Utang marang Modal RVNC